Connect with us

CBD

FDA announces possible framework for hemp derived CBD based products

mm

Published

on

FDA

Image Source: Time Magazine

The Food and Drug Administration allows hemp derived CBD oil only in a drug that treats two rare forms of epilepsy in children. Despite of the federal law which passed the Farm bill in 2018 and made hemp derived CBD oil a legal substance, the FDA holds back its decision.

The farm bill removed hemp, a cannabis genus plant with extremely low concentrations of tetrahydro cannabinoid (THC) from the Controlled Substance Act, no longer classifying it as a controlled drug under the federal law.

The legal hemp products can contain THC in almost negligible traces with less than 0.3% concentration, anything above this is termed as illegal and the owner can be prosecuted for the same. THC is basically a psychoactive substance which causes the ‘high’ when people smoke weed.

It can lead up to severe mental disorders such as epilepsy, seizures, Alzheimer’s, hallucinations, stress, forgetfulness and many other diseases. Contrarily, CBD or cannabinoid has anti-inflammatory properties with a non-psychoactive nature.It helps reduce stress, anxiety, depression, seizures and can even help treat epilepsy.

Though these benefits are not internationally journaled or researched, consumers have experienced a positive impact after using CBD oil.

The FDA currently bans any sort of CBD infused edible and prohibits selling them to consumers. On the other hand, the growing curiosity of consumers about its possible potential health benefits has led to many companies and retailers selling CBD infused products.

The safest bet for business leaders all over the country is to invest in beauty and lifestyle products based on CBD rather than foods and drinks infused with the drug. After causing much chaos in the public and amongst the business domain, the FDA announced to hold a public hearing on May 31 to discuss the regulatory policies for CBD oil.

The agency said that it is taking essential steps in order to determine a framework for lawful marketing and production of appropriate cannabis and cannabis derived products.

The hearing will serve as a broader opportunity for written public comment for stakeholders to share their real life experiences with the product entailing information about their views related to its safety. The FDA’s approved framework for legal cannabis usage will also include the formation of a new high-level internal agency to explore pathways for dietary supplements or conventional foods infused with CBD to be marketed legally.

The FDA webpage will contain all the frequently asked questions (FAQ’s) on the topic to assist consumers and companies to understand how the FDA’s requirements apply to these products.

The FDA and FTC jointly issued warning letters to 3 companies recently for false marketing of their CBD products which claimed that they can help treat Cancer and Alzheimer’s. These actions are a significant step for the legal and controlled marketing of hemp derived CBD oils and its products.

Hemp is listed in the Substance II category in Ohio, however the Ohio Senate voted unanimously and legalized hemp-derived products, including CBD oil. The bill now moves on to the Ohio House of Representatives.

The regulatory issues will be solved and clear once the FDA has set its framework and policies for the substance. Despite of the confusion, several companies and retailers have introduced CBD infused foods and drinks to the front shelves for consumers. Though there have not been many cases for strict actions against them, the Health officials can seize all the products and arrest the owner for doing so.

I'm Ivan Green. I worked as a former journalist and a member of the 'Writers for Marijuana Society'. I spend my most of the time in covering Cannabis News all over the world. You can ask questions or send feedback on Ivan@thecannabisradar.com

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

We Love: